Michaela Kuhlen1, Andrea Hönscheid2, Janina Schemme3, Hartmut Merz3, Christine Mauz-Körholz4, Arndt Borkhardt2, Anja Troeger5. 1. Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Duesseldorf, Germany. Michaela.Kuhlen@med.uni-duesseldorf.de. 2. Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Duesseldorf, Germany. 3. Department of Pathology, Medical University of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany. 4. Department of Pediatrics, Martin-Luther University Medical Center, Halle, Germany. 5. Pediatric Hematology and Oncology, Children's Hospital Medical Centre, University of Bonn, Bonn, Germany.
Abstract
UNLABELLED: DICER1 germline mutations are associated with an inherited cancer syndrome, most commonly presenting with pleuropulmonary blastoma (PPB), ovarian sex cord tumors, thyroid cysts/goitre, and cystic nephroma. We describe the occurrence of a Hodgkin lymphoma (HL) of the T cell phenotype in a family with DICER1 syndrome. The patient presented with PPB Type I and HL. Immunohistochemical staining of the Hodgkin and Reed-Sternberg cells revealed CD30, TGP, CD2, CD3, CD15, and IRF4 positivity and weekly positivity of PAX5. T cell receptor repertoire analysis suggested HL of T cell origin, which is in contrast to common B cell-derived HL. The mother had been diagnosed with thyroid cysts, one sister had died from a primitive neuroectodermal tumor, and a brother had died from PPB Type III. Two mutational events were revealed in all affected family members; a single bp deletion, c.5299delC, leading to a frameshift and premature stop in exon 24 and a heterozygous variant (c.4616C>T; p.Thr1539Met) located in exon 23 of the DICER1 gene. This variant is predicted to be benign by in silico analysis. CONCLUSION: Future studies looking for DICER1 mutations in HL cases of the T cell phenotype will be important to confirm its association with constitutional DICER1 syndrome. WHAT IS KNOWN: • DICER1 germline mutations are associated with an inherited cancer syndrome, most commonly pleuropulmonary blastoma, ovarian sex cord tumors, thyroid cysts/goitre, and cystic nephroma. • Hodgkin lymphoma is one of the most frequent types of malignant lymphomas and typically arises sporadically. T cell-derived Hodgkin lymphomas are exceptionally rare. What is New: • DICER1 syndrome may have an even broader phenotypic spectrum and seems to be associated with rare forms of T cell Hodgkin lymphoma.
UNLABELLED: DICER1 germline mutations are associated with an inherited cancer syndrome, most commonly presenting with pleuropulmonary blastoma (PPB), ovarian sex cord tumors, thyroid cysts/goitre, and cystic nephroma. We describe the occurrence of a Hodgkin lymphoma (HL) of the T cell phenotype in a family with DICER1 syndrome. The patient presented with PPB Type I and HL. Immunohistochemical staining of the Hodgkin and Reed-Sternberg cells revealed CD30, TGP, CD2, CD3, CD15, and IRF4 positivity and weekly positivity of PAX5. T cell receptor repertoire analysis suggested HL of T cell origin, which is in contrast to common B cell-derived HL. The mother had been diagnosed with thyroid cysts, one sister had died from a primitive neuroectodermal tumor, and a brother had died from PPB Type III. Two mutational events were revealed in all affected family members; a single bp deletion, c.5299delC, leading to a frameshift and premature stop in exon 24 and a heterozygous variant (c.4616C>T; p.Thr1539Met) located in exon 23 of the DICER1 gene. This variant is predicted to be benign by in silico analysis. CONCLUSION: Future studies looking for DICER1 mutations in HL cases of the T cell phenotype will be important to confirm its association with constitutional DICER1 syndrome. WHAT IS KNOWN: • DICER1 germline mutations are associated with an inherited cancer syndrome, most commonly pleuropulmonary blastoma, ovarian sex cord tumors, thyroid cysts/goitre, and cystic nephroma. • Hodgkin lymphoma is one of the most frequent types of malignant lymphomas and typically arises sporadically. T cell-derived Hodgkin lymphomas are exceptionally rare. What is New: • DICER1 syndrome may have an even broader phenotypic spectrum and seems to be associated with rare forms of T cell Hodgkin lymphoma.
Entities:
Keywords:
DICER1 syndrome; Hodgkin lymphoma; T cell type
Authors: Leanne de Kock; Harriet Druker; Evan Weber; Nancy Hamel; Jeffrey Traubici; David Malkin; Jocelyne Arseneau; Colin J R Stewart; Dorothée Bouron-Dal Soglio; John R Priest; William D Foulkes Journal: Hum Pathol Date: 2015-03-05 Impact factor: 3.466
Authors: Amin Bahubeshi; Nebil Bal; Thomas Rio Frio; Nancy Hamel; Carly Pouchet; Ahmet Yilmaz; Dorothée Bouron-Dal Soglio; Gretchen M Williams; Marc Tischkowitz; John R Priest; William D Foulkes Journal: J Med Genet Date: 2010-10-29 Impact factor: 6.318
Authors: A Bräuninger; M L Hansmann; J G Strickler; R Dummer; G Burg; K Rajewsky; R Küppers Journal: N Engl J Med Date: 1999-04-22 Impact factor: 91.245
Authors: Leslie Doros; Jiandong Yang; Louis Dehner; Christopher T Rossi; Kerry Skiver; Jason A Jarzembowski; Yoav Messinger; Kris Ann Schultz; Gretchen Williams; Nicolas André; D Ashley Hill Journal: Pediatr Blood Cancer Date: 2011-12-16 Impact factor: 3.167
Authors: John R Priest; Gretchen M Williams; Ricarchito Manera; Helen Jenkinson; Marie-Anne Bründler; Samuel Davis; Timothy G Murray; Carlos A Galliani; Louis P Dehner Journal: Br J Ophthalmol Date: 2010-12-13 Impact factor: 4.638
Authors: John R Priest; Gretchen M Williams; William A Mize; Louis P Dehner; Michael B McDermott Journal: Int J Pediatr Otorhinolaryngol Date: 2010-09-06 Impact factor: 1.675
Authors: D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow Journal: Science Date: 2009-06-25 Impact factor: 47.728
Authors: M Müschen; K Rajewsky; A Bräuninger; A S Baur; J J Oudejans; A Roers; M L Hansmann; R Küppers Journal: J Exp Med Date: 2000-01-17 Impact factor: 14.307
Authors: Marta Tijerin Bueno; Claudia Martínez-Ríos; Alejandro De la Puente Gregorio; Rayan A Ahyad; Anita Villani; Harriet Druker; Kalene van Engelen; Bailey Gallinger; Laura Aronoff; Ronald Grant; David Malkin; Mary-Louise C Greer Journal: Pediatr Radiol Date: 2017-05-04
Authors: Jette J Bakhuizen; Helen Hanson; Karin van der Tuin; Fiona Lalloo; Marc Tischkowitz; Karin Wadt; Marjolijn C J Jongmans Journal: Fam Cancer Date: 2021-06-25 Impact factor: 2.446